Skip to main content
. Author manuscript; available in PMC: 2012 Apr 25.
Published in final edited form as: Inflamm Bowel Dis. 2008 Nov;14(11):1528–1541. doi: 10.1002/ibd.20512

TABLE 8.

Logistic Regression Modeling Without and With Risk Genes

Without Risk Genes in Model
With Risk Genes in Model
OR 95% CI P-value OR 95% CI P-value
Age (<30 y/o vs. >=30 y/o) 3.88 (1.96–7.69) <0.001 3.57 (1.71–7.46) 0.001
Gender (female vs. male) 0.56 (0.37–0.85) 0.006 0.58 (0.37–0.91) 0.02
Residency (urban vs. rural) 1.01 (0.68–1.49) 0.98 1.05 (0.68–1.62) 0.82
Positive family history of IBD 2.41 (1.31–4.42) 0.005 2.75 (1.42–5.31) 0.003
Tobacco use 1.84 (1.25–2.71) 0.002 2.06 (1.35–3.14) 0.001
Jewish ethnicity 17.1 (2.12–138.3) 0.008 20.1 (2.16–186.8) 0.008
Carrier of NOD2 mutation 4.45 (2.68–7.38) <0.001
Carrier of ATG16L1 1.88 (1.09–3.24) 0.02
Carrier of rs10889677 2.13 (1.39–3.28) 0.001
Carrier of IBD5_IGR2230 2.16 (1.30–3.59) 0.003